scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1011879366 |
P356 | DOI | 10.1038/GT.2014.43 |
P932 | PMC publication ID | 4324603 |
P698 | PubMed publication ID | 24830437 |
P5875 | ResearchGate publication ID | 262381597 |
P2093 | author name string | M Zhang | |
J C Glorioso | |||
W F Goins | |||
P R Kinchington | |||
J-M G Guedon | |||
P2860 | cites work | Neurological disease produced by varicella zoster virus reactivation without rash | Q27694488 |
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults | Q28254168 | ||
Quantitative assessment of tactile allodynia in the rat paw | Q29617366 | ||
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia | Q29620385 | ||
An HSV vector system for selection of ligand-gated ion channel modulators | Q33293071 | ||
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life | Q33611436 | ||
The variegate neurological manifestations of varicella zoster virus infection | Q33732991 | ||
Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin | Q33792025 | ||
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). | Q34012075 | ||
Spinal astrocytic activation is involved in a virally-induced rat model of neuropathic pain | Q34039405 | ||
Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination | Q34158156 | ||
Live vaccine used to prevent the spread of varicella in children in hospital | Q34202755 | ||
Varicella-zoster viruses associated with post-herpetic neuralgia induce sodium current density increases in the ND7-23 Nav-1.8 neuroblastoma cell line | Q34575055 | ||
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus | Q35069305 | ||
Gene therapy for pain: results of a phase I clinical trial | Q35154100 | ||
Two alphaherpesvirus latency-associated gene products influence calcitonin gene-related peptide levels in rat trigeminal neurons | Q35753952 | ||
Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception | Q36634794 | ||
Complications of varicella zoster virus reactivation | Q37119278 | ||
Replication-defective herpes simplex virus vectors for gene transfer in vivo | Q37248260 | ||
Animal models of pain: progress and challenges | Q37405925 | ||
Varicella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models | Q37625435 | ||
Varicella zoster: an update on current treatment options and future perspectives | Q38167380 | ||
Transgene-mediated expression of tumor necrosis factor soluble receptor attenuates morphine tolerance in rats | Q38490798 | ||
Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs | Q38603800 | ||
Development of a live attenuated varicella vaccine | Q39940850 | ||
Varicella-zoster virus open reading frame 66 protein kinase is required for efficient viral growth in primary human corneal stromal fibroblast cells. | Q41337775 | ||
Pharmacology and mechanisms of opioid analgesic activity | Q41374982 | ||
Treatment of inflamed pancreas with enkephalin encoding HSV-1 recombinant vector reduces inflammatory damage and behavioral sequelae | Q41422386 | ||
HSV-mediated p55TNFSR reduces neuropathic pain induced by HIV gp120 in rats through CXCR4 activity | Q42241894 | ||
Enkephalin-encoding herpes simplex virus-1 decreases inflammation and hotplate sensitivity in a chronic pancreatitis model | Q43111345 | ||
Effects of transgene-mediated endomorphin-2 in inflammatory pain | Q43161654 | ||
Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion | Q43586557 | ||
Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE). | Q43621268 | ||
Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. | Q43864219 | ||
Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain | Q43907419 | ||
Reversal of ongoing thermal hyperalgesia in mice by a recombinant herpesvirus that encodes human preproenkephalin | Q44741126 | ||
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain | Q44963501 | ||
Intrathecal herpes simplex virus type 1 amplicon vector-mediated human proenkephalin reduces chronic constriction injury-induced neuropathic pain in rats | Q45367619 | ||
Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs | Q45423431 | ||
Behavioural changes in the rat following infection with varicella-zoster virus | Q45747025 | ||
Opioids modulate pain facilitation from the dorsal reticular nucleus | Q46412552 | ||
Joint capsule treatment with enkephalin-encoding HSV-1 recombinant vector reduces inflammatory damage and behavioural sequelae in rat CFA monoarthritis | Q46684381 | ||
Recombinant herpes vector-mediated analgesia in a primate model of hyperalgesia | Q46804409 | ||
Engineering an endomorphin-2 gene for use in neuropathic pain therapy | Q48224100 | ||
Postherpetic neuralgia in immunocompetent elderly people | Q48786475 | ||
Efficient analysis of experimental observations. | Q52767736 | ||
Allodynia in rats infected with varicella zoster virus—a small animal model for post-herpetic neuralgia | Q59853775 | ||
Pain and somatosensory dysfunction in acute herpes zoster | Q77925426 | ||
Herpes vector-mediated expression of proenkephalin reduces bone cancer pain | Q78433906 | ||
Attenuation of pain-related behavior in a rat model of trigeminal neuropathic pain by viral-driven enkephalin overproduction in trigeminal ganglion neurons | Q81532062 | ||
P433 | issue | 7 | |
P921 | main subject | enkephalin | Q325101 |
vector-borne disease | Q2083837 | ||
P304 | page(s) | 694-702 | |
P577 | publication date | 2014-05-15 | |
P1433 | published in | Gene Therapy | Q15763095 |
P1476 | title | Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin | |
P478 | volume | 21 |
Q37670799 | Antinociceptive Effect of Intrathecal Injection of Genetically Engineered Human Bone Marrow Stem Cells Expressing the Human Proenkephalin Gene in a Rat Model of Bone Cancer Pain |
Q35658521 | Current gene therapy using viral vectors for chronic pain |
Q38761087 | Lateral thalamic control of nociceptive response after whisker pad injection of varicella zoster virus |
Q92511043 | Modeling Varicella Zoster Virus Persistence and Reactivation - Closer to Resolving a Perplexing Persistent State |
Q35668407 | Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo |
Q35706635 | Neuronal changes induced by Varicella Zoster Virus in a rat model of postherpetic neuralgia |
Q45026393 | Role for the Ventral Posterior Medial/Posterior Lateral Thalamus and Anterior Cingulate Cortex in Affective/Motivation Pain Induced by Varicella Zoster Virus |
Q33702943 | Sex differences underlying orofacial varicella zoster associated pain in rats |
Q28072338 | The oral and craniofacial relevance of chemically modified RNA therapeutics |
Search more.